Guardian Pharmacy Services (NYSE:GRDN) Reaches New 12-Month High – What’s Next?

Guardian Pharmacy Services, Inc. (NYSE:GRDN) reached a new 52-week high during mid-day trading on Friday . The stock traded as high as $41.79 and last traded at $41.58, with a volume of 124747 shares traded. The stock had previously closed at $40.80.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on GRDN. Oppenheimer raised their price target on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. Jefferies Financial Group began coverage on shares of Guardian Pharmacy Services in a research report on Monday, March 30th. They issued a “buy” rating and a $44.00 price target on the stock. Zacks Research lowered shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Bank of America began coverage on shares of Guardian Pharmacy Services in a research report on Monday, April 27th. They issued a “buy” rating and a $42.00 price target on the stock. Finally, Raymond James Financial restated an “outperform” rating and issued a $40.00 price target on shares of Guardian Pharmacy Services in a research report on Thursday, March 12th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Guardian Pharmacy Services has a consensus rating of “Moderate Buy” and an average target price of $41.33.

Guardian Pharmacy Services Trading Down 0.5%

The business’s fifty day moving average price is $37.65 and its 200 day moving average price is $33.59. The company has a market capitalization of $2.02 billion, a P/E ratio of 48.91, a P/E/G ratio of 2.66 and a beta of 0.08.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.05. The company had revenue of $336.60 million during the quarter, compared to the consensus estimate of $329.89 million. Guardian Pharmacy Services had a net margin of 3.64% and a return on equity of 30.72%. The firm’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period last year, the firm earned $0.22 EPS. Equities research analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current year.

Insider Activity at Guardian Pharmacy Services

In related news, Director Thomas J. Salentine, Jr. sold 3,570,677 shares of Guardian Pharmacy Services stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $29.68, for a total transaction of $105,977,693.36. Following the completion of the transaction, the director directly owned 4,469,316 shares of the company’s stock, valued at $132,649,298.88. This trade represents a 44.41% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director John Ackerman sold 1,103,364 shares of Guardian Pharmacy Services stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $29.68, for a total transaction of $32,747,843.52. Following the transaction, the director directly owned 345,123 shares of the company’s stock, valued at $10,243,250.64. This represents a 76.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 9,726,405 shares of company stock worth $288,679,700 in the last ninety days. Company insiders own 32.96% of the company’s stock.

Hedge Funds Weigh In On Guardian Pharmacy Services

Institutional investors have recently added to or reduced their stakes in the company. Ameritas Investment Partners Inc. lifted its holdings in Guardian Pharmacy Services by 26.5% during the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after purchasing an additional 345 shares during the last quarter. Raymond James Financial Inc. bought a new position in Guardian Pharmacy Services during the 2nd quarter valued at about $43,000. Strs Ohio bought a new position in Guardian Pharmacy Services during the 4th quarter valued at about $75,000. Clearstead Advisors LLC lifted its holdings in Guardian Pharmacy Services by 196.3% during the 4th quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock valued at $79,000 after purchasing an additional 1,741 shares during the last quarter. Finally, State of Wyoming bought a new position in Guardian Pharmacy Services during the 2nd quarter valued at about $58,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.